Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes
Abstract Human noroviruses are non-enveloped, single-strand RNA viruses that cause pandemic outbreaks of acute gastroenteritis. A bivalent vaccine containing GI.1 and GII.4 virus-like particles (VLPs) has been shown to be safe and highly immunogenic, but its efficacy and durability have been limited...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/291f486fe191490c902890335db78af5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:291f486fe191490c902890335db78af5 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:291f486fe191490c902890335db78af52021-12-02T12:42:26ZDisulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes10.1038/s41541-020-00260-w2059-0105https://doaj.org/article/291f486fe191490c902890335db78af52020-12-01T00:00:00Zhttps://doi.org/10.1038/s41541-020-00260-whttps://doaj.org/toc/2059-0105Abstract Human noroviruses are non-enveloped, single-strand RNA viruses that cause pandemic outbreaks of acute gastroenteritis. A bivalent vaccine containing GI.1 and GII.4 virus-like particles (VLPs) has been shown to be safe and highly immunogenic, but its efficacy and durability have been limited. Here, we show that norovirus GI.1 VLPs are unstable and contain a substantial fraction of dissociated VLP components. Broadly reactive, non-neutralizing antibodies isolated from vaccinated donors bound to the dissociated components, but not to the intact VLPs. Engineering of interprotomer disulfide bonds within the shell domain prevented disassembly of the VLPs, while preserving antibody accessibility to blockade epitopes. Without adjuvant, mice immunized with stabilized GI.1 VLPs developed faster blockade antibody titers compared to immunization with wild-type GI.1 VLPs. In addition, immunization with stabilized particles focused immune responses toward surface-exposed epitopes and away from occluded epitopes. Overall, disulfide-stabilized norovirus GI.1 VLPs elicited improved responses over the non-disulfide-stabilized version, suggesting their promise as candidate vaccines.Raffaello VerardiLisa C. LindesmithYaroslav TsybovskyJason GormanGwo-Yu ChuangCaitlin E. EdwardsPaul D. Brewer-JensenMichael L. MalloryLi OuArne SchönWei ShiEna S. TullyGeorge GeorgiouRalph S. BaricPeter D. KwongNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 5, Iss 1, Pp 1-10 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Raffaello Verardi Lisa C. Lindesmith Yaroslav Tsybovsky Jason Gorman Gwo-Yu Chuang Caitlin E. Edwards Paul D. Brewer-Jensen Michael L. Mallory Li Ou Arne Schön Wei Shi Ena S. Tully George Georgiou Ralph S. Baric Peter D. Kwong Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes |
description |
Abstract Human noroviruses are non-enveloped, single-strand RNA viruses that cause pandemic outbreaks of acute gastroenteritis. A bivalent vaccine containing GI.1 and GII.4 virus-like particles (VLPs) has been shown to be safe and highly immunogenic, but its efficacy and durability have been limited. Here, we show that norovirus GI.1 VLPs are unstable and contain a substantial fraction of dissociated VLP components. Broadly reactive, non-neutralizing antibodies isolated from vaccinated donors bound to the dissociated components, but not to the intact VLPs. Engineering of interprotomer disulfide bonds within the shell domain prevented disassembly of the VLPs, while preserving antibody accessibility to blockade epitopes. Without adjuvant, mice immunized with stabilized GI.1 VLPs developed faster blockade antibody titers compared to immunization with wild-type GI.1 VLPs. In addition, immunization with stabilized particles focused immune responses toward surface-exposed epitopes and away from occluded epitopes. Overall, disulfide-stabilized norovirus GI.1 VLPs elicited improved responses over the non-disulfide-stabilized version, suggesting their promise as candidate vaccines. |
format |
article |
author |
Raffaello Verardi Lisa C. Lindesmith Yaroslav Tsybovsky Jason Gorman Gwo-Yu Chuang Caitlin E. Edwards Paul D. Brewer-Jensen Michael L. Mallory Li Ou Arne Schön Wei Shi Ena S. Tully George Georgiou Ralph S. Baric Peter D. Kwong |
author_facet |
Raffaello Verardi Lisa C. Lindesmith Yaroslav Tsybovsky Jason Gorman Gwo-Yu Chuang Caitlin E. Edwards Paul D. Brewer-Jensen Michael L. Mallory Li Ou Arne Schön Wei Shi Ena S. Tully George Georgiou Ralph S. Baric Peter D. Kwong |
author_sort |
Raffaello Verardi |
title |
Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes |
title_short |
Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes |
title_full |
Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes |
title_fullStr |
Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes |
title_full_unstemmed |
Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes |
title_sort |
disulfide stabilization of human norovirus gi.1 virus-like particles focuses immune response toward blockade epitopes |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/291f486fe191490c902890335db78af5 |
work_keys_str_mv |
AT raffaelloverardi disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes AT lisaclindesmith disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes AT yaroslavtsybovsky disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes AT jasongorman disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes AT gwoyuchuang disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes AT caitlineedwards disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes AT pauldbrewerjensen disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes AT michaellmallory disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes AT liou disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes AT arneschon disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes AT weishi disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes AT enastully disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes AT georgegeorgiou disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes AT ralphsbaric disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes AT peterdkwong disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes |
_version_ |
1718393673574514688 |